
CAS Number111-02-4
Synonyms(6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; (E,E,E,E)-Squalene; 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; (all-E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; Squalene; triacontahexaene; Spinacen; EINECS 203-826-1; Supraene; MFCD00008912; SQUALENE OIL; SPINACENE; (6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; Squalen; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene; trans-Spinacene
Molecular Formula[(CH3)2C[=CHCH2CH2C(CH3)]2=CHCH2-]2
Molecular Weight410.72
Purity≥98%
Density0.8±0.1 g/cm3
Boiling Point285 °C/25 mmHg (lit.)
Melting Point−75 °C (lit.)
Appearanceliquid
EINECS203-826-1
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 111-02-4 |
| Catalog No. | 2A-9018782 |
| Chinese Name | 角鲨烯 |
| Synonyms | (6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; (E,E,E,E)-Squalene; 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; (all-E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; Squalene; triacontahexaene; Spinacen; EINECS 203-826-1; Supraene; MFCD00008912; SQUALENE OIL; SPINACENE; (6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; Squalen; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene; trans-Spinacene |
| Molecular Formula | [(CH3)2C[=CHCH2CH2C(CH3)]2=CHCH2-]2 |
| Molecular Weight | 410.72 |
| Purity | ≥98 |
| Density | 0.8±0.1 g/cm3 |
| Boiling Point | 285 °C/25 mmHg (lit.) |
| Melting Point | −75 °C (lit.) |
| Appearance | liquid |
| Water Solubility | <0.1 g/100 mL at 19 ºC |
| Storage Condition | Store in a cool, ventilated warehouse. Keep away f |
| Packaging | II; III |
| Application | Squalene is an intermediate product of cholesterol synthesis and has a variety of pharmacological activities, such as lowering blood lipids, protecting liver, protecting the heart, antioxidant and ant |
| EINECS | 203-826-1 |
| HTC | 29012980 |
| PubChem ID | 24899564 |
| MDL Number | MFCD00008912 |
| SMILES | CC(C)=CCCC(C)=CCCC(C)=CCC\C=C(/C)CCC=C(C)CCC=C(C)C |
| InChI | 1S/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24+ |
| InChI Key | YYGNTYWPHWGJRM-AAJYLUCBSA-N |
| Beilstein/REAXYS | 1728919 |
| NACRES Code | NA.25 |
| UNSPSC | 12352212 |
| Hazard Symbols | 4.1 |
| MSDS | msds/18782_1_111_02_4.pdf |
| Bioactivity | Squalene is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, cardioprotective, antioxidant, and antitoxicant activity. Related Catalog Research Areas >> Cardiovascular Disease Research Areas >> Infection Natural Products >> Terpenoids and Glycosides Target Human Endogenous Metabolite References [1]. Muzalevskaya EN, et al. SQUALENE: PHYSIOLOGICAL AND PHARMACOLOGICAL PROPERTIES. Eksp Klin Farmakol. 2015;78(6):30-6. Chemical & Physical Properties Density 0.8±0.1 g/cm3 Boiling Point 429.3±0.0 °C at 760 mmHg Melting Point −75 °C(lit.) Molecular Formula C30H50 Molecular Weight 410.718 Flash Point 254.1±22.2 °C Exact Mass 410.391266 LogP 13.09 Vapour Pressure 0.0±0.5 mmHg at 25°C Index of Refraction 1.492 InChIKey YYGNTYWPHWGJRM-AAJYLUCBSA-N SMILES CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C Storage condition 2-8°C Water Solubility <0.1 g/100 mL at 19 ºC |
| Use of | Squalene is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, cardioprotective, antioxidant, and antitoxicant activity. Properties Articles122 Name squalene Synonym More Synonyms Squalene Biological Activity Description Squalene is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, cardioprotective, antioxidant, and antitoxicant activity. Related Catalog Research Areas >> Cardiovascular Disease Research Areas >> Infection Natural Products >> Terpenoids and Glycosides Human Endogenous Metabolite References [1]. Muzalevskaya EN, et al. SQUALENE: PHYSIOLOGICAL AND PHARMACOLOGICAL PROPERTIES. Eksp Klin Farmakol. 2015;78(6):30-6. Chemical & Physical Properties Molecular Formula C30H50 Exact Mass 410.391266 LogP 13.09 Index of Refraction 1.492 InChIKey YYGNTYWPHWGJRM-AAJYLUCBSA-N SMILES CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C |
| Tax Rebate | 9.0% |
| Supervision | none |
| Transport Info | Product name: Purity: 96.0% |
| MSDS Transport Info | Module 14. Shipping information United Nations classification: inconsistent with United Nations classification standards UN number: not specified |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Dihydropyran | 110-87-2 | 2A-9018770 |
| 6-Methyl-5-hepten-2-one | 110-93-0 | 2A-9018774 |
| 1,1'-Oxydi-2-propanol | 110-98-5 | 2A-9018779 |
| Diglycolic acid | 110-99-6 | 2A-9018780 |
| Squalane | 111-01-3 | 2A-9018781 |
| Methyl octanoate | 111-11-5 | 2A-9018783 |
| Methyl 2-octynoate | 111-12-6 | 2A-9018784 |
| 3,3'-Thiodipropionic acid | 111-17-1 | 2A-9018789 |
| 4-Methoxy-1-butanol | 111-32-0 | 2A-9018799 |
| n-Butyl vinyl ether | 111-34-2 | 2A-9018801 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA